FIELD: medicine, dermatology.
SUBSTANCE: the present innovation deals with treating focal scleroderma. Moreover, it is necessary to inject preparation "Collagenase CC" intradermally directly into pathological focus due to multiple injections at therapeutic dosage for the depth of about 2-3 mm at the distance approximately 1 cm against each other, moreover, therapy course consists of 10-20 seances which should be carried out once during 7-10 d. The innovation is very efficient due to preparation's penetration into pathological focus for the depth of 2-3 mm.
EFFECT: more simplified method of therapy.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CICATRICE TREATMENT | 2005 |
|
RU2286791C1 |
| METHOD FOR TREATMENT OF KRAUROSIS VULVAE IN WOMEN IN THE MENOPAUSAL AND POSTMANOPASUAL PERIOD | 2016 |
|
RU2662424C2 |
| METHOD OF TREATING MORPHEA | 2010 |
|
RU2424008C1 |
| METHOD FOR TREATING LOCALIZED SCLERODERMA | 2004 |
|
RU2264815C2 |
| METHOD OF COMBINATION THERAPY OF CIRCUMSCRIBED SCLERODERMIA WITH APPLYING LOCAL TRANSDERMAL ENZYMIC ELECTROSTATIC EXPOSURE | 2009 |
|
RU2403921C1 |
| METHOD OF TREATING PATHOLOGICAL CICATRICAL SKIN DEFORMITIES | 2015 |
|
RU2599868C1 |
| METHOD FOR TREATING ALOPECIA | 2001 |
|
RU2194515C1 |
| METHOD OF TREATMENT OF CHRONIC SALPINGOPOURITIS | 2017 |
|
RU2681927C1 |
| METHOD OF TREATMENT OF PATIENTS WITH CIRCUMSCRIBED SCLERODERMA | 0 |
|
SU1461455A1 |
| METHOD OF TREATING PATIENTS WITH LOCALISED SCLERODERMA | 2014 |
|
RU2564905C1 |
